3.8 Review

Summary and comparison of recently updated post-polypectomy surveillance guidelines

期刊

INTESTINAL RESEARCH
卷 21, 期 4, 页码 443-451

出版社

KOREAN ASSOC STUDY INTESTINAL DISEASES
DOI: 10.5217/ir.2023.00107

关键词

Polypectomy; Surveillance; Guidelines; Colonoscopy; Colorectal polyp

向作者/读者索取更多资源

Recently, updated guidelines for post-polypectomy surveillance have been published by multiple societies, and this review summarizes and compares the recommendations of these guidelines. There are differences in the recommended surveillance intervals, particularly for different types of adenomas. Surveillance recommendations for patients with serrated polyps are limited, and more research is needed in this area.
Recently, updated guidelines for post-polypectomy surveillance have been published by the U.S. Multi-Society Task Force (USMSTF), the British Society of Gastroenterology/Association of Coloproctology of Great Britain and Ireland/Public Health England (BSG/ACPGBI/PHE), the European Society of Gastrointestinal Endoscopy (ESGE), the Japan Gastroenterological Endoscopy Society (JGES), and the Korean Multi-Society Taskforce Committee. This review summarizes and compares the updated recommendations of these 5 guidelines. There are some differences between the guidelines for the recommended post-polypectomy surveillance intervals. In particular, there are prominent differences between the guidelines for 1-4 tubular adenomas < 10 mm with low-grade dysplasia (nonadvanced adenomas [NAAs]) and tubulovillous or villous adenomas. The USMSTF, JGES, and Korean guidelines recommend colonoscopic surveillance for patients with 1-4 NAAs and those with tubulovillous or villous adenomas, whereas the BSG/ACPGBI/PHE and ESGE guidelines do not recommend endoscopic surveillance for such patients. Surveillance recommendations for patients with serrated polyps (SPs) are limited. Although the USMSTF guidelines provide specific recommendations for patients who have undergone SPs removal, these are weak and based on very low quality evidence. Future studies should examine this topic to better guide the surveillance recommendations for patients with SPs. For countries that do not have separate guidelines, we hope that this review article will help select the most appropriate guidelines as per each country's healthcare environment. (Intest Res 2023;21:443-451 )

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

3.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据